Table 7.
Postprocedural course and 30-day outcome
| Need for pacemaker (n) | 1 (12.5%) |
| AKI with need for RRT (n) | 0 (0%) |
| Minor access site bleeding (n) | 3 (37.5%) |
| Stroke (n) | 1 (12.5%) |
| Pre discharge echocardiography | |
| LVEF (%) | 48.6 (± 20.9) |
| LVEDD (mm) | 51.6 (± 18.9) |
| Interventricular septum (mm) | 13.1 (± 4.8) |
| AV Pmean (mmHg) | 7.8 (± 4.2) |
| AV Pmax (mmHg) | 15 (± 7.2) |
| PVLPVL | |
| 0 | 4 (50%) |
| II | 4 (50%) |
| MI | |
| I | 4 (50%) |
| II | 4 (50%) |
| TI | |
| 0 | 2 (25%) |
| I | 4 (50%) |
| II | 2 (25%) |
| Systolic PAP (mmHg) | 38 (± 38.1) |
| 30-day mortality (n) | 0 (0%) |
Data is shown as mean (± standard deviation) or frequency (%)
AKI acute kidney injury, AV aortic valve, LVEDD left ventricular end-diastolic diameter, LVEF left ventricular ejection fraction, MI mitral valve insufficiency, PAP systolic pulmonary artery pressure, Pmean mean valvular gradient, Pmax maximal valvular gradient, PVL paravalvular leakage, RRR renal replacement therapy, TI tricuspid valve insufficiency